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To identify variation in antenatal management of multiple pregnancy. The UK has 10,000 twin pregnancies per year. There is established guidance on the management of dichorionic (DC) and monochorionic (MC) twin pregnancy from both the RCOG and NICE, however it is likely that the provision and practice of multiple pregnancy management varies amongst units.
Design
Questionnaires were posted to 151 UK maternity units in 3 rounds from May to November 2019. 
Results
60 responses were received (range 11500 to 501 deliveries), with annual multiple pregnancy rates of 190 to 4. 25% of units did not offer a dedicated twin clinic and less than 15% of units provided dedicated multiple pregnancy midwifery staff for intrapartum and postnatal care. Cervical length screening was performed in 24% of units with 84% of units offering treatment for a short cervix. 15% of units prescribed Aspirin to all multiples, 47% prescribing 75mg and 43% 150mg. Monitoring of MC pregnancies varied with 18% of units not measuring Middle Cerebral Artery and 29% Ductus Venosus Dopplers. Mean caesarean section rate was 61.7%. Delivery was offered from 37 weeks in 93% of DC twins and from 36 weeks in 90% MC twins. 5% of MC twins were given non labouring prophylactic antenatal steroids.
Conclusion
Despite well-established national guidance for twin pregnancy management there remains a wide variation in practice among units in the provision and antenatal management of multiple pregnancies throughout the UK. The exact reasons for this variation require further exploration.
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The incidence of multiple pregnancies over the last 30 years has risen exponentially due to the use of assisted reproductive techniques, with rates doubling to 10,000 multiple pregnancy births in 2018 [1]. Due to the substantial risks associated with multiple pregnancy and its largely preventable nature within IVF, the UK Human Fertilisation and Embryology Authority (HFEA) introduced a maximum live multiple birth rate target of 10% in 2008, reducing rates from 24% down to an average of 10% in 2017 [2]. Despite this, multiple pregnancies still account for around 15 per 1000 women giving birth within England and Wales and up to 79 per 1000 in the over 45 age group [1]. These pregnancies are associated with significant risk of adverse maternal and fetal outcomes, as well as significant costs to the National Health Service (NHS).
Compared to singleton pregnancies, multiple pregnancies are associated with increased maternal morbidity (anaemia, hypertensive disorders, venous thromboembolism, obstetric cholestasis and gestational diabetes), and pregnancy complications such as; miscarriage, preterm birth, caesarean section and post-partum haemorrhage. In addition, monochorionic twin pregnancies carry additional unique risks of twin to twin transfusion syndrome (TTTS), and/or selective fetal growth restriction (sFGR), approximately 15% each, and a 13% risk of twin anaemia-polycythaemia sequence (TAPS) in those who have undergone laser therapy as a treatment for TTTS [3,4,5]. 
The fetal risks involved in twin pregnancies are also significant with 1 in 12 multiple pregnancies ending in death or disability for one or more babies [6]. The preterm birth rate is 60% prior to 37 weeks with 10% delivering before 32 weeks and 11.5% of babies admitted to Neonatal Intensive Care Units (NICU) are from multiple pregnancies despite only accounting for 1.6% of live births [7,8,9]. The significant adverse maternal and fetal outcomes pose significant challenges for clinicians and contribute to the average cost of caring for a multiple pregnancy being almost three times as much as a singleton pregnancy [6].
Within the UK there are established guidelines for the management of twin and higher order pregnancies from The Royal College of Obstetricians and Gynaecologists (RCOG) on monochorionic twin pregnancies and The National Institute for Health and Care Excellence (NICE) which published revised multiple pregnancy guidelines in 2019 [7,10]. 
Despite these well-established national guidelines, there has been concern about variations in practice. A 2015 maternity services survey reported that only 10-18% of UK maternity units had been able to fully implement key quality standards within the previous 2011 NICE multiple pregnancy guideline - reflecting the complexities that multiple pregnancy present and the additional specialist services that they require [11-13]. This prompted the Maternity Engagement Project by the Twins Trust charity, an initiative to improve outcomes within multiple pregnancies by promoting the NICE quality standard within targeted maternity units around the UK. Over a 3-year period, selected units showed significant improvement in adherence to NICE quality standard as well as improved patient outcomes and associated cost saving [14].
We designed this national survey to ascertain the current provision of antenatal care for multiple pregnancies in the UK and to identify any variations in practice to allow for targeted strategies to improve care universally..
2.	Method
The survey (Appendix A) with covering letter was mailed to the clinical lead for obstetrics in  a 151 consultant led NHS trusts providing maternity servicesunits within the UK (England, Wales, Scotland, Northern Ireland, Channel Islands and Isle of Man (IOM)) including all 132 NHS trusts within England, from a historic database from previously published surveys [15]. The questionnaires were sent ininitially in two rounds in  three rounds in May and, September 2019, with a 3rd added in and November 2019 due to the lower than anticipated response rate. The questionnaire comprised of 34 questions, 16 of which covered general antenatal care and service provision for multiple pregnancy as well as protocols for screening and prevention of preterm birth. A further 18 questions concerned the antenatal management of monochorionic and dichorionic pregnancies to explore local approaches to caring for these specific pregnancies. Responses were analysed by question and expressed as a percentage of the total responses per question received in both exclusive and non-exclusive multiple-choice questions.
3.	Results
60/151 units responded giving a response rate of 40% and within England alone 49/132 (37%). The size of the units ranged from 501 to 11,500 deliveries; 21 units had >5000 deliveries, 34 units ranged from 2000-4999 and 5 units had <2000 deliveries (1 unit did not state). The number of multiple pregnancies per unit ranging from 4 to 190 and 18% (11/60) of units responded were tertiary fetal medicine centres. Geographically, 49 units were based within England, 5 within Scotland, 3 within NI, and 1 from both IOM and Channel Islands.
A small number of questionnaires were not completed fully, answers that were provided have been included within the results and percentages have been calculated from total number of responses per question,.
All units prescribed aspirin therapy to multiple pregnancy routinely, the dose varied, with 47% (28/60) giving 75mg and 43% (26/60) giving 150mg with 10% (6/60) of units varying the dose dependent on BMI. 85% of units prescribed Aspirin when one or more risk factors were present, with the other 15% giving to all multiple pregnancies, regardless of other risk factors. Growth charts for multiple pregnancy were used in just over two thirds of units (40/59, 68%) with GROW being the most commonly used growth chart (26/59 44%). Regarding growth discordance cut off values, just under half (29/59, 49%) of units used a 20% cut off, 37% (22/59) of units used a 25% cut off, 7% (4/59) did not use discordance and a further 7% (4/59) used other values including 15%, chorionicity dependent and subjective measures. Combined screening was offered in 82% (49/60) units for dichorionic pregnancies and 81% (46/57) monochorionic. See Table 1.

Aspirin Therapy	n=60
All Multiple PregnanciesIf other risk factors only	9 (15)51 (85)
Aspirin Dose	n=60
75mg150mgOther	28 (47)26 (43)6 (10)
Aneuploidy Screening (non- exclusive)	MC n=57	DC n=60
Combined QUAD	46 (81)19 (33)	49 (82)21 (35)
Growth Charts Used	n=59
GROWTAMBAOtherNone	26 (44)7 (12)7 (12)19 (32)
Growth Discordance Parameters Used	n=59
20%25%OtherDid not use	29 (49)22 (37)4 (7)4 (7)
Table 1. Antenatal management. n (%). MC – Monochorionic. DC – Dichorionic.

Dedicated twin clinics were provided by 67% (40/60) of units and 80% (47/59) of units had named clinical leads ranging from midwives to sub-specialist fetal medicine clinicians. Only 46% (27/59) of units had a lead midwife for multiple pregnancy and could offer dedicated antenatal care and less than a fifth could offer dedicated intrapartum and postnatal care. (Table 2). 
Dedicated Clinics	n=60
Yes - Monochorionic and DichorionicYes – Monochorionic onlyYes – Singletons also * None	28 (47)12 (20)5 (8)15 (25)
Clinical Lead	n=59
ObstetricianObstetrician and GynaecologistFetal Medicine SpecialistMidwifeNo clinical lead	12 (20)9 (15)25 (43)1 (2)12 (20)
Dedicated multiple pregnancy	n=59










Table 2. Service Provision. n (%)
*Non-Twin pregnancies also present in same clinic

14/58 (24%) units offered cervical length screening, 3/14 units (21%) offered this only in a research capacity and 9/14 (64%) units performed serial scanning.  Cervical length scanning was commenced at varying times amongst units performing them; 12 weeks (3), 16 weeks (5), 20 weeks (3) and 24 weeks (1). Units were also asked if they would treat a short cervix in a multiple pregnancy and what intervention they would use with nine units (16%) not treating a short cervix (Table 3).
Screening for cervical length	n=58
Yes No	14 (24)44 (76)
Interventions for short cervix in twins (non-exclusive)	n= 58
Vaginal ProgesteroneIM ProgesteroneArabin PessaryCervical CerclageNone	37 (64)1 (2)10 (17)25 (43)9 (16)
Table 3 – Treatment of short cervix in twins. n (%)

Regarding timing of delivery, almost all units offered delivery from 37 weeks (56, 93%) in dichorionic pregnancies with only four units routinely offering delivery from 38 weeks. Monochorionic pregnancies were similar with 90% (54) of units offering delivery from 36 weeks with the remaining offering from 37 weeks. Surprisingly prophylactic antenatal steroids were offered by 1 unit for all dichorionic pregnancies after 36 weeks and 5% (3) of units for all monochorionic pregnancies between 30 and 36 weeks’ gestation. Steroid administration prior to induction of labour and elective caesarean section are seen below (Table 4). The mean caesarean section rate amongst units was 61.7%.

Steroids for Induction of Labour	MC (n=60)	DC (n=59)
Yes if <34+0 weeksYes if <35+0 weeksYes if <36+0 weeksYes if <37+0 weeksNo	7 (12)3 (5)15 (25)10 (17)25 (42)	8 (14)4 (7)10 (17)7 (12)30 (51)
Steroids for Elective C/S	MC (n=60)	DC (n=59)
Yes – allYes if <34+0 weeksYes if <35+0 weeksYes if <36+0 weeksYes if <37+0 weeksNo	34 (57)1 (2)1(2)5 (8)18 (30)1(2)	33 (56)0 (0)1 (2)3 (5)18 (31)4 (7)
Table 4. Steroid Administration. n (%)
MC Monochorionic, DC Dichorionic

We asked a series of questions specifically around the management of monochorionic pregnancies to determine standard practice. This included the monitoring of Middle Cerebral Artery Doppler (MCA); 40% (24/60) of units measured this at each visit and 18% (11/60) reported never measuring MCA. Similarly, 17 units (29%) reported never measuring Ductus Venosus (DV) Doppler in monochorionic twins. Of the responses that we received, only 7% (4) units performed laser for TTTS (Table 5).

Measurement of MCA Doppler	n=60
Yes – every visitPost laser cases onlyNeverSelected cases (sFGR/TTTS/TAPs)	24 (40)2 (3)11 (18)23 (38)
Measurement of DV Doppler	n=58
Yes – every visitPost laser cases onlyNeverSelected cases	10 (17)4 (7)17 (29)27 (47)
Table 5. Monochorionic monitoring. n (%)

4.	Discussion
Our survey is unique in assessing the current real-life situation for clinical services providing antenatal care for women with a multiple pregnancy in the UK. Other recent reports have been able to demonstrate similar findings in relation to the routine antenatal care and service provision available for multiple pregnancies in the UK [16]. However, the specialist screening and interventions in relation to preterm birth and complications of monochorionic pregnancies have not been examined despite their presence within NICE and prior RCOG guidance [7,10]. We feel these elements are critical in understanding how specialist care recommended for multiple pregnancies is truly being translated into clinical practice. Within state funded health care systems, it is often assumed that consistent care can be provided throughout the country. Whilst we have been able to demonstrate this in some aspects of care for multiple pregnancies, there remain wide variations in some practices, which may reflect difficulty complying with national guidance.
This study is limited in being UK based suggesting that interpretation to other settings should be done with caution. In addition, despite multiple survey periods the response was less than anticipated although a range of sizes of units were represented across the UK, which should reflect standard practice. There is the potential however of participation bias, with those units responding having more of an interest in multiple pregnancies and service provision compared to non-respondents. The revised NICE guidance was also published during our study period with some units potentially updating their practice in this time, however the themes addressed in the following discussion were either not updated in the new revision or updated in line with previously published RCOG guidelines. It is also important to emphasise this study aimed to address the variations in UK practice rather than adherence to NICE guidance. A total of 6/60 questionnaires were returned incomplete, commonly unanswered questions included whether cervical length screening was performed and interventions for a short cervix along with invasive testing performed. This may represent the lack of guidance regarding prediction and prevention of pre term birth in twins and potentially a lack of specialist knowledge of invasive procedures amongst those completing the questionnaire.
Reassuringly all of the units provided aspirin therapy to reduce the risk of hypertensive disorders. The NICE 2019 Hypertension in Pregnancy guidance lists multiple pregnancy as a moderate risk factor for pre-eclampsia, recommending antiplatelet agents when more than one moderate risk factor is present [17]. A small proportion deviated from NICE in giving aspirin to all pregnancies regardless of risk factors, however it is important to note other countries’ national guidance would advocate this [18]. Consensus was also shown for timing of delivery of monochorionic and dichorionic twins, with only 10% and 7% respectively deferring delivery by 1 week, again although deviating, in keeping with other countries’ national guidance [19,20]. 
There was a wide variation in service provision between units, despite NICE guidance recommending a core team of specialist obstetrician and midwives for multiple pregnancy, with 20% of units having no named clinical lead and over half had no named midwifery lead. This may well be due to the low number of multiple pregnancies in some units and the feasibility of offering such a service, however this questionnaire was unable to determine this as the only factor.
Our survey highlighted further variations in practice with up to 20% of twin pregnancies not offering combined aneuploidy screening, despite this being a recommendation within the NHS Fetal Anomaly Screening Programme (FASP). It is very difficult to interpret why this well-established guideline does not appear to be being implemented for twin pregnancies.  In addition, the management of growth discordance also displayed wide variation with 14% of units either not recording sFGR or using values that are not suggested by the RCOG or NICE despite the increased risk of perinatal morbidity and mortality at the specified 25% discordance with one fetus less than the 10th centile [7]. 
Inconsistent management was also observed in the use of routine antenatal steroids for fetal lung maturity in non-labouring monochorionic and dichorionic pregnancies, at 5% and 2% of units respectively. The use of elective steroids in this context has not been advised by NICE or RCOG or within Canadian, United States of America or New Zealand guidance on steroid administration [21-23]. 
Both NICE and RCOG recommends measurement of MCA Doppler in monochorionic pregnancies treated with laser for TTTS and those complicated by sFGR with  [7]. RCOG also advocatinge measurement of DV Doppler at diagnosis of TTTS, post laser therapy and in cases of sFGR with an abnormal UA Doppler [7,10]. Responses from the questionnaire found that almost a third of units did not measure DV Doppler and 18% did not measure MCA Doppler at all. As all units managing monochorionic twin pregnancies are performing screening to identify cases of TTTS this leads to inconsistencies in the approach to screening between units and may reduce the quality of care provided for some mothers of monochorionic twins. 
Finally, the lack of national guidance in relation to the use of growth charts was evident from the wide variation in practice amongst units. Although a number of growth charts are available for use in multiple pregnancy no single chart holds precedence. They remain a contentious subject; whether twin pregnancy growth trajectory should follow that of a singleton, whether charts should be customised or population based and what validation exists for such charts are just a few issues that until addressed will encourage variation in practice. 
5.	Conclusion
It is reassuring that significant consistency exists in many aspects of antenatal care provided for multiple pregnancies, however variation is also evident. This raises concern that the effect of national guidance on the management of multiple pregnancy has more limited impact on management than would perhaps have been assumed, especially in relation to the screening and management of complicated multiple pregnancies. This may reflect difficulties in adhering to guidance that relies heavily upon the use of ultrasound and may in part be due lack of experienced clinicians and ultrasonographers for multiple pregnancy. It may also reflect the low numbers of cases of multiple pregnancies within some units, which may preclude a dedicated service. 
This survey also highlights the need for a greater quality of evidence for a standardised approach to the screening and prevention of preterm birth in multiple pregnancy. Prematurity is the main contributing factor to perinatal morbidity and mortality and therefore identifying those at highest risk of pre term birth should be a priority. There is clearly a desire from some clinical teams to provide a service for cervical length screening with 24% offering cervical length assessment and 84% offering treatment should a short cervix be identified. 
We would suggest further exploration into why some units appear unable to implement specific national recommendations to find the limiting factors involved with the aim of standardised care throughout the UK either by improving local resources or by greater centralisation of multiple pregnancy care. 
6.	Declaration
None of the authors report a conflict of interest.
7.	Funding
No funding was received for this study.
8.	Contribution of Authorship
AS, SN and AK conceived idea. AS and JG performed the survey and analysed the data. JG prepared manuscript.  AS, SN and AK reviewed and provided internal critique of the manuscript.
9.	Ethics
This was a survey of practice and contained no patient identifiable data and therefore did not require ethical review.
10.	References
1.	[Dataset] National Office of Statistics. Birth Characteristics 2018. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/datasets/birthcharacteristicsenglandandwales (​https:​/​​/​www.ons.gov.uk​/​peoplepopulationandcommunity​/​birthsdeathsandmarriages​/​livebirths​/​datasets​/​birthcharacteristicsenglandandwales​). Accessed 24/3/20
2.	HFEA. Fertility treatment 2017: trends and figures. May 2019. https://www.hfea.gov.uk/media/2894/fertility-treatment-2017-trends-and-figures-may-2019.pdf (​https:​/​​/​www.hfea.gov.uk​/​media​/​2894​/​fertility-treatment-2017-trends-and-figures-may-2019.pdf​) Accessed 24/3/20
3.	Kilby MD, Baker PN, Critchley HO, Field DJ, editors. Consensus views arising from the 50th Study Group: Multiple Pregnancy. In:Multiple Pregnancy. London: RCOG Press; 2006. p. 283–6
4.	Slaghekke F, Lopriore E, Lewi L, Middeldorp JM, van Zwet EW,Weingertner AS, et al. Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial. Lancet 2014;383:2144–51
5.	Lewi L, Deprest J. Management of twin pregnancies: where do we go from here? Ultrasound Obstet Gynecol 2013;41:601–4.
6.	National Guideline Alliance. Twin Pregnancy Costing – a comparative analysis of the additional costs to the NHS of twin pregnancy relative to a singleton pregnancy. https://hfea.gov.uk/media/2650/nga-twin-pregnancy-costing-final.pdf (​https:​/​​/​hfea.gov.uk​/​media​/​2650​/​nga-twin-pregnancy-costing-final.pdf​). Accessed 24/3/20
7.	NICE. Twin and triplet pregnancy (NG 137) London. National Institute for health and Care Excellence; 2019
8.	Neonatal Data Analysis Unit (NDAU). Neonatal Data Analysis Unit 2016 Report. http://www.imperial.ac.uk/media/imperial-college/medicine/dept-medicine/infectious-diseases/neonatology/NDAU-2016-Report-v1.1(002).pdf (​http:​/​​/​www.imperial.ac.uk​/​media​/​imperial-college​/​medicine​/​dept-medicine​/​infectious-diseases​/​neonatology​/​NDAU-2016-Report-v1.1(002).pdf​). Accessed 24/3/20
9.	Murray, SR, Stock, SJ, Cowan, S, Cooper, ES, Norman, JE. Spontaneous preterm birth prevention in multiple pregnancy. The Obstetrician & Gynaecologist 2018; 20; 57– 63. DOI: 10.1111/tog.12460 (​https:​/​​/​doi.org​/​10.1111​/​tog.12460" \t "_blank" \o "Link to external resource: 10.1111​/​tog.12460​).
10.	RCOG. Management of monochorionic twin pregnancy. Green top guideline No. 51. November 2016.
11.	NICE. NICE impact maternity. May 2018. https://www.nice.org.uk/media/default/about/what -we-do/into-practice/measuring-uptake/nice-impact-maternity.pdf (​https:​/​​/​www.nice.org.uk​/​media​/​default​/​about​/​what%20-we-do​/​into-practice​/​measuring-uptake​/​nice-impact-maternity.pdf​). Accessed 24/3/20
12.	NICE. Multiple Pregnancy: Antenatal care for twin and triplet pregnancies (CG129) London. National Institute for health and Care Excellence; 2011
13.	Fox R, Reed K, McMullen S, Windmill H. Maternity Services and Multiple Births. TAMBA and NCT Joint Report 2015. https://twinstrust.org/uploads/assets/30985846-9bc2-4660-a641642828419b9e/Maternity-Services-for-Multiples-Tamba-NCT-Joint-Report-r2-2.pdf. Accessed 24/3/20.
14.	TAMBA. Twins and Multiple Births Association Maternity Engagement Project Final Report. 2019. https://twinstrust.org/uploads/assets/afcc44b3-776e-4341-8a16e9bd990c3425/NICE-works-final-report.pdf. Accessed 1/4/20 (​https:​/​​/​twinstrust.org​/​uploads​/​assets​/​afcc44b3-776e-4341-8a16e9bd990c3425​/​NICE-works-final-report.pdf. Accessed 1​/​4​/​20​)
15.	Sharp A, Duong C, Agarwal U, Alfirevic Z. Screening and management of the small for gestational age fetus in the UK: A survey of practice. Eur J Obstet Gynecol Reprod Biol. 2018;231:220-224. doi:10.1016/j.ejogrb.2018.10.039

16.	Twins Trust. BeCOME. Better Care of Multiple – an exploration. Research Report. 2020. https://twinstrust.org/uploads/assets/5632cbad-a219-446d-b31efabdb7557e76/7c3543e7-8592-407e-a8daa9f59ac7ba32/BeCOME-Report.pdf (​https:​/​​/​twinstrust.org​/​uploads​/​assets​/​5632cbad-a219-446d-b31efabdb7557e76​/​7c3543e7-8592-407e-a8daa9f59ac7ba32​/​BeCOME-Report.pdf​) Accessed 24/4/20
17.	NICE. Hypertension in Pregnancy: diagnosis and management (NG 133) London. National Institute for health and Care Excellence 2019.
18.	ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet. Gynecol. 2019;133:e1–e25.
19.	Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Care, Health Service Executive. Management of Multiple Pregnancy. Guideline No. 14. June 2012.
20.	The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of monochorionic twin pregnancy. July 2017.
21.	Skoll A, Boutin A, Bujold E, et al. No. 364-antenatal corticosteroid therapy for improving neonatal outcomes. J Obstet Gynaecol Can.2018;40:1219-1239
22.	ACOG Practice Bulletin No. 169. Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies. Obstet Gynecol 2016;128:e131–46.




11.	Appendix A – Antenatal Survey
Survey of Antenatal Management of Multiple Pregnancies

The UK has 11,000 twin pregnancies per year (2% of all births). There is established guidance on the management of dichorionic and monochorionic twin pregnancy from NICE and the RCOG. However it is likely that the provision and practice of multiple pregnancy management varies between units. 
We would like to understand more about how the antenatal management of multiple pregnancy varies and have composed this survey to address this. 


1)	How many deliveries in your unit in the past year?  	________________________

2)	How many multiple pregnancies in the past year?  	________________________

3)	What is your CS rate for twins?				________________________%

4)	Do you give aspirin to multiple pregnancies?  
a)	All multiple pregnancies
b)	Only if additional risk factors
c)	No






6)	Do you have a dedicated twin clinic?
a)	Yes – for monochorionic and dichorionic twins
b)	Yes – but we only see monochorionic twins










8)	Who is the clinical lead for this service? (choose most suitable)
a)	Obstetrician
b)	Obstetrician and Gynaecologist
c)	Fetal medicine Specialist (ATSM trained)




9)	Do you have a midwife lead for multiple pregnancies?
Yes		No

10)	Do you have midwifery staff who provide a dedicated multiple pregnancy antenatal care?
Yes		No

11)	Do your multiple pregnancy midwifery staff also provide the following services?

a)	Multiple pregnancy specific antenatal classes						
Yes		No
b)	Intrapartum care to all multiple pregnancies					
Yes		No
c)	Intrapartum care to multiple pregnancies having elective caesarean section 	
Yes		No

d)	Postnatal care in the community						
Yes		No

12)	Do you perform cervical length screening for preterm birth screening? 
a)	No
b)	Yes
a.	If yes at what gestation? _________________
b.	Do you perform serial measurements?		Yes		No

13)	Would you treat a short cervix in twins? (circle all that apply)
a)	Yes – Vaginal Progesterone
b)	Yes – IM Progesterone
c)	Yes – Arabin Pessary





14)	Do you use fetal fibronectin in asymptomatic twin pregnancy?
a)	No
b)	Yes
a.	If yes at what gestation? _________________
 
15)	What cut off do you use to define Growth discordance?
a)	20%
b)	25% 
c)	We don’t do this
d)	Other ________________________

16)	Do you use fetal growth charts for multiple pregnancy?
a)	Yes - TAMBA
b)	Yes - GROW





17)	Do you offer aneuploidy screening for DICHORIONIC twin pregnancies? (circle all that apply)
a)	Combined screening
b)	Screening with NT only




18)	If high risk, what invasive procedure would you offer DICHORIONIC twins? (circle all that apply)
a)	CVS
b)	Amniocentesis – single sac
c)	Amniocentesis – double sac
d)	Refer to another unit

19)	Who performs the screening scans for DICHORIONIC multiple pregnancies? 
a)	Obstetrician
b)	Obstetrician and Gynaecologist
c)	Fetal medicine Specialist (ATSM trained)












21)	Do you offer prophylactic antenatal corticosteroids without evidence of labour for DICHORIONIC twin pregnancies? 
a)	Yes – 28-30 weeks
b)	Yes – 30-34+0 weeks




22)	Do you offer corticosteroids for all inductions of labour in DICHORIONIC twin pregnancies? 
a)	Yes – if <34+0 weeks
b)	Yes – if <35+0 weeks
c)	Yes – if <36+0 weeks
d)	Yes – if <37+0 weeks
e)	No

23)	 Do you offer corticosteroids for all elective caesareans in DICHORIONIC twin pregnancies? 
a)	Yes – all
b)	Yes – if <34+0 weeks
c)	Yes – if <35+0 weeks
d)	Yes – if <36+0 weeks





24)	Do you offer aneuploidy screening for MONOCHORIONIC twin pregnancies? (circle all that apply)
a)	Combined screening
b)	Screening with NT only




25)	If high risk, what invasive procedure would you offer MONOCHORIONIC twins (circle all that apply)? 
a)	CVS
b)	Amniocentesis – single sac
c)	Amniocentesis – Double sac
d)	Refer to another unit

26)	Who performs the screening scans for MONOCHORIONIC multiple pregnancies? 
a)	Obstetrician
b)	Obstetrician and Gynaecologist
c)	Fetal medicine Specialist (ATSM trained)












28)	Do you monitor Ductus Venosus in all MONOCHORIONIC twins? 
a)	Yes, at each visit
b)	Only in post fetoscopic laser cases
c)	Never
d)	In selected cases (Example) ________________________

29)	Do you monitor Middle Cerebral Artery Doppler (PI and PSV) in all MONOCHORIONIC twins? 
a)	Yes, at each visit
b)	Only in post fetoscopic laser cases
c)	Never 
d)	In selected cases (Example) ________________________

30)	Do you routinely offer fetal MRI in women post laser for TTTS
a)	Yes - 6 weeks post laser
b)	Yes - at 28 weeks
c)	Yes - Other ________________________
d)	No






32)	Do you offer prophylactic antenatal corticosteroids without evidence of labour for MONOCHORIONIC twin pregnancies? 
a)	Yes – 28-30 weeks
b)	Yes – 30-34+0 weeks
c)	Yes – after 36+0 weeks
d)	No

33)	Do you offer corticosteroids for all induction of labour in MONOCHORIONIC twin pregnancies? 
a)	Yes – if <34+0 weeks
b)	Yes – if <35+0 weeks
c)	Yes – if <36+0 weeks
d)	Yes – if <37+0 weeks
e)	No

34)	 Do you offer corticosteroids for all elective caesareans in MONOCHORIONIC twin pregnancies? 
a)	Yes – all
b)	Yes – if <34+0 weeks
c)	Yes – if <35+0 weeks
d)	Yes – if <36+0 weeks
e)	Yes – if <37+0 weeks
f)	No

Thank you for your time in completing this questionnaire

12.	Appendix B - Results
Frequency of Clinic	n=59
Twice WeeklyWeeklyFortnightly Other	3 (5)34 (58)5 (8)17 (29)
FFN in Asymptomatic Twins	n=59
YesNo	1 (2)58 (98)
Routine MRI post Laser for TTTS	n=59
Yes – 6 weeks postYes – 28 weeksYes – OtherNo	8 (16)8 (16)16 (27)27 (46)
Invasive Procedures (non-exclusive)	MCn=57	DCn=57
CVSAmnio Single SacAmnio Double SacRefer Onwards	15 (26)10 (18)13 (23)36 (63)	12 (21)8 (14)19 (33)36 (63)
Personal Performing screening scans(non-exclusive)	MCn=58	DCn=60
ObstetricianObstetrician & GynaecologistFMU ATSMFMU SubspecialistMidwifeUltrasonographerOther	2 (3)1 (2)9 (16)10 (17)2 (3)37 (64)3 (5)	2 (3)1 (2)5 (8)5 (8)3 (5)48 (80)2 (3)


n (%). MC – Monochorionic. DC – Dichorionic.
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